Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3
- PMID: 10713699
- DOI: 10.1038/sj.onc.1203412
Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3
Abstract
Members of the NF-kappa B/Rel transcription factor family have been shown recently to be required for cellular transformation by oncogenic Ras and by other oncoproteins and to suppress transformation-associated apoptosis. Furthermore, NF-kappa B has been shown to be activated by several oncoproteins including HER2/Neu, a receptor tyrosine kinase often expressed in human breast cancer. Human breast cancer cell lines, human breast tumors and normal adjacent tissue were analysed by gel mobility shift assay, immunoblotting of nuclear extracts and immunohistochemistry for activation of NF-kappa B. Furthermore, RNA levels for NF-kappa B-activated genes were analysed in order to determine if NF-kappa B is functionally active in human breast cancer. Our data indicate that the p65/RelA subunit of NF-kappa B is activated (i.e., nuclear) in breast cancer cell lines. However, breast tumors exhibit an absence or low level of nuclear p65/RelA but show activated c-Rel, p50 and p52 as compared to nontumorigenic adjacent tissue. Additionally, the I kappa B homolog Bcl-3, which functions to stimulate transcription with p50 or p52, was also activated in breast tumors. There was no apparent correlation between estrogen receptor status and levels of nuclear NF-kappa B complexes. Transcripts of NF-kappa B-regulated genes were found elevated in breast tumors, as compared to adjacent normal tissue, indicating functional NF-kappa B activity. These data suggest a potential role for a subset of NF-kappa B and I kappa B family proteins, particularly NF-kappa B/p52 and Bcl-3, in human breast cancer. Additionally, the activation of functional NF-kappa B in these tumors likely involves a signal transduction pathway distinct from that utilized by cytokines.
Similar articles
-
Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.Cancer Res. 2003 Mar 1;63(5):1059-66. Cancer Res. 2003. PMID: 12615723
-
The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.Clin Cancer Res. 1999 Jan;5(1):119-27. Clin Cancer Res. 1999. PMID: 9918209
-
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.J Clin Invest. 1997 Dec 15;100(12):2952-60. doi: 10.1172/JCI119848. J Clin Invest. 1997. PMID: 9399940 Free PMC article.
-
Regulation and function of IKK and IKK-related kinases.Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13. Sci STKE. 2006. PMID: 17047224 Review.
-
Aberrant rel/nfkb genes and activity in human cancer.Oncogene. 1999 Nov 22;18(49):6938-47. doi: 10.1038/sj.onc.1203221. Oncogene. 1999. PMID: 10602468 Review.
Cited by
-
IκBζ: an emerging player in cancer.Oncotarget. 2016 Oct 4;7(40):66310-66322. doi: 10.18632/oncotarget.11624. Oncotarget. 2016. PMID: 27579619 Free PMC article. Review.
-
Elevated NIBP/TRAPPC9 mediates tumorigenesis of cancer cells through NFκB signaling.Oncotarget. 2015 Mar 20;6(8):6160-78. doi: 10.18632/oncotarget.3349. Oncotarget. 2015. PMID: 25704885 Free PMC article.
-
Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells.Cancer Sci. 2009 Oct;100(10):1834-41. doi: 10.1111/j.1349-7006.2009.01260.x. Epub 2009 Jul 24. Cancer Sci. 2009. PMID: 19681904 Free PMC article.
-
Constitutive non-canonical NFkappaB signaling in pancreatic cancer cells.Cancer Biol Ther. 2009 Aug;8(16):1567-76. doi: 10.4161/cbt.8.16.8961. Epub 2009 Aug 8. Cancer Biol Ther. 2009. PMID: 19502791 Free PMC article.
-
Macrophages orchestrate breast cancer early dissemination and metastasis.Nat Commun. 2018 Jan 2;9(1):21. doi: 10.1038/s41467-017-02481-5. Nat Commun. 2018. PMID: 29295986 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous